The effect of Bombyx mori larvae extract in reducing the toxicity of methotrexate in pregnant female albino rats
Methotrexate (MTX) is an anticancer agent which is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, cutaneous T cell lymphoma, and lung cancer. Bombyx mori larvae have a huge value as health food especially for cardiac and diabetic patients, bronchial asthma, primary trigeminal neuralgia, vocal nodules and polyps and in the treatment of facial palsy and pain. In the present study meeting occurred under the normal conditions and about 40 pregnant female rats were used. Herein the pregnant females will be divided into five groups; group 1 will be used as negative control received distilled water, group 2 will used as positive control and recived buffer of Bombyx mori larvae extract, group 3 was treated with MTX at the 12th day of gestation (at organogenesis phase), group 4 was treated with Bombyx mori larvae extract at 7th , 9th , 11th ,13th and 15th days of gestation (during the oraganogensis period), & group 5 was injected by MTX the 12th day of gestation as well as bombyx mori larvae extract at 7th ,9th ,11th ,13th &15th days of gestation. Animals of all groups will be sacrificed at 20th day, the end of gestation periods. Then livers of all pregnant rats were removed for examination. The obtained results showed decrease in maternal body weight gain plus increase in the abortion rate and uterine weight in the MTX-treated group. In addition, MTX induced an elevation in the examined liver oxidative stress biomarkers plus myeloperoxidase activity and decrease in reduced glutathione content and catalase activity; in mothers. Histopathological studies of liver tissues showed congestion of central vein of mothers in MTX group showing ballooning degeneration of hepatocytes, perivascular inflammatory cells infiltration and strong deposition of collagen fibers. Noteworthy, Bombyx mori larvae induced marked improvement in injuries associated with MTX administration.
Keywords: Methotrexate, Bombyx mori larvae, Pregnant female rats, Hepatotoxicity.
2- Fernandez JC, Kaplowitz N.Hepatic mitochondrial glutathione transport and role in disease and toxicity. Toxicol. Appl. Pharmacol., 2005; 204: 263–273.
3- Sabayan B, Foroughinia F,Chohedry A. A postulated role of garlic organosulfur compounds in prevention of valproic acid hepatotoxicity. Medical Hypotheses, 2007; 68: 512-514.
4- Perry, Michael J. The Chemotherapy source book. Philadelphia: Wolters Kluwer Health/Lippincott .Williams & Wilkins, 2008; 978-0-7817-7328-7.
5- Sneader, Walter. Drug Discovery: A History. John Wiley & Sons. 2005; p. 251.
6- Vardi N, Parlakpinar H, Cetin A, Erdogan A, Cetin I . Protective effect of beta-carotene on methotrexate-induced oxidative liver damage. Toxicologic pathology, 2010; 38(4): 592-597.
7- Sanders K, Moran Z, Shi Z, Paul R, Greenlee H. Natural products for cancer prevention: Clinical Update 2016. Semin Oncol Nurs., 2016;32:215–240.
8- Hamamoto H, Tonoike A, Narushima K, Horie R, Sekimizu K. Silkworm as model organism to evaluate drug candidate toxicity and metabolism. Comparative Biochemistry and Physiology: Toxicology and Pharmacology, 2008; 149(3):334–339.
9- Khan MD, Saha BN. Growth and development of the mulberry silkworm, Bombyx mori L. on feed supplemented with alanine and glutamine. Sericolgia. 1995; 35:657–663.
10- Marumoto Y, Teruuchi T, Enjoh T, Numata F, Sakano K. Purification and refolding of recombinant human IGF IIfrom silkworms infected with recombinant Bombyx morinuclear polyhedrosis virus. Biosci Biotech Biochem .,1992;56:13–16.
11- Ishibashi J, Kataoka H, Nagasawa H, Isogai A, Suzuki A.Isolation and identification of adipokinetic hormone of the silkworm, Bombyx mori. Biosci Biotech Biochem., 1992; 56:66-70.
12- Jouni ZE, Wells MA. Purification and partial character-ization of a lutein-binding protein from the midgut of the silkworm, Bombyx mori. J Biol Chem., 1996; 271: 14722–14726.
13- Shinohara T, Aso Y, Shirai K, Fuji H, Funatsu G .Purifi-cation of Chymotrypsin inhibitors from larval hemolymphof the silkworm, Bombyx mori. Biosci Biotech Biochem., 1993; 57:1067–1071
14- Nagamatsu Y, Yanagisawa I, Kimoto M, Okamoto E, Koga I. Purification of a chitooligosaccharidolytic b-N-acetylglucosaminidase from Bombyx morilarvae duringmetamorphosis and the nucleotide sequence of its cDNA. Biosci Biotech Biochem., 1995; 59: 219–225
15- Aso Y, Yamamoto K, Yoshinaga T, Yamamoto H, Yamagami T. Partial purification and characterisation of DOPAQuinone Imine conversion factor from larval hemolymphof the silkworm, Bombyx mori. Biosci Biotech Biochem ,1995;59:277–281.
16- Datta RK . Silkworms to produce human vaccine. Indian Silk., 1994;33: 33–35.
17- De Z. Treatment of bronchial asthma with Ningxiao Drink in 85 patients. Shandong J Trad Chin Med., 1991;10:23.
18- Hai H .Treatment of 376 cases of male infertility with Zengjing pill. Jiangxi J Trad Chin Med., 1989; 20: 10–11.
19- TuchmannH. Methods for evaluating teratognic properties of new drugs. In:"Methods in Drug Evaluation." North-Holand publishing company, 1966.
20- Banerjee BN, Durlopo RS.Incidence of teratological anomalies controls charles River C-D strain rats. Toxico., 1973; 1: 151-154.
21- Wilson JG. Mechanisms of teratogenisis. Am. J. Anat., 1973;136(2): 129-131.
22- Tuchmann H. Drug effect on the fetus: General principles of drug induced congenital abnormalities. ADIS Press, 1977; 39.
23- Edwards JA. The external development of the rabbit and rat embryo In "Advances in Teratology", 3, Woollham, D.H.M.; Ed., Academic Press, 1968; 239.
24- Snell GD.Biology of the laboratory Mouse, 5th ed .The Blakiston company, philadeliphia., 1956.
25- McClain RM, BeckerB A. Teratogenicity, foetal toxicity and placental transfer of lead nitrate in rats. Toxicol. App.l Pharmacol., 1975;(1): 72-82.
26- Coleshowers CL, Oguntibeju OO, Ukpong M, Truter EJ .Effects Of Methotrexate On Antioxidant Enzyme Status In A Rodent Model. Medical Technology SA., 2010; 24 (1): 5-9.
27- Cho MR, Choue R, Chung SH, Ryu JW. Effect of silkworm powders on blood glucose and blood lipid concentrations of non-insulin dependent (Type 2) diabetes patients. Korean J. Nutrition, 1998; 31: 1139-1150.
28- Nounou MM, El-Khordagui LK, Khalafallah N. Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles. Acta Pol. Pharm, 2005; 62, 369-379.
29- Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology, 1982; 78(3):206–209.
30- Miranda KM, Espey MG, Wink DA.Arapid simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide, 2001; 5 (1): 62-71.
31- Armitage P, Berry G.Comparison of several groups. In: Blackwell Scientific Publications, 1987;186-213.
32- de Koning BA, van Dieren JM, Lindenbergh DJ, van der Sluis M, Matsumoto T, Yamaguchi K, et al.contributions of mucosal immune cells to methotrexate-induced mucositis. International immunology, 2006; 18(6):941-949.
33- Tajuddin M, Ahmad NN. Effect of Unani formulation on lipid profile in rat. Indian J Pharmacol., 2006;38:56–7.
34- Ramakanth, Raman KVA .Cocoon Pelade for betterhealth. Indian Silk., 1997; 35: 35.
35- Mao XJ, Mao XP, Xiao QC, Jiang Q, Yang XY. Pharmacological study of antifertility on Bombyx batryticatus. J. Yunnan Coll. Tradit. Chin. Med., 2002;25: 26–28.
36- Iikuni N, Iwami S, Kasai S, Tokuda H. Intern Med., 2004 ;43(9):846-51.
37- Çetin A, Kaynar L, Kocyigit I, et al. Role of grape seed extract on methotrexate induced oxidative stress in rat liver. The American Journal of Chinese Medicine., 2008;36(5):861–872.
38- KimHJ, LeeWH,YoonCH, Jeong JC, Nam KS, Kim HM,ChooYK, Lee MC,KimCH. Bombycis corpus extract prevents amyloid-beta-induced cytotoxicity and protects superoxide dismutase activity in cultured rat astrocytes. Pharmacol. Res., 2001; 43:11–16.
39- Vardi N, Parlakpinar H, Cetin A, Erdogan A, Ozturk IC. Protective effect of β-carotene on methotrexate-induced oxidative liver damage. Toxicologic Pathology., 2010; 38(4):592–597.
40- Hu MB, Wang J L, Liu Y J, Yuan X, Li J H, Wu CJ, Li L. Structure characterization and antioxidant properties of proteins extracted from the larva of Bombyx mori L. Tropical Journal of Pharmaceutical Res., 2018; 17(11).
41- Zhao Q, Huo LQ, Jia TZ. Effects of Different Processing Methods on in vitro Antioxidant Activity and Inhibiting Capacity for Tyrosinase of Bombyx batryticatus. Chin. J. Exp. Tradit. Med. Form, 2014; 20: 17–23.
42- Xing DX, Liao ST, Luo GQ, Li L, Xiao Y, Li QR, Ye MQ, Yang Q.Extraction process optimization and antioxidant activity determination of polysaccharide from Bombyx batryticatus. Sci. Seri., 2015; 41: 1088– 1093.
43- Cetinkaya A, Bulbuloglu E ,Kurutas EB, Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Medical science monitor., 2006; 12(8): 274-278.
44- Ohbayashi M, Suzuki M, Yashiro Y, Fukuwaka S, Yasuda M, Kohyama N, Kobayashi Y, Yamamoto T. Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. The Journal of toxicological sciences, 2010;35(5): 653-661.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).